LURASIDONE Drug Patent Profile
✉ Email this page to a colleague
When do Lurasidone patents expire, and when can generic versions of Lurasidone launch?
Lurasidone is a drug marketed by Accord Hlthcare, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Annora Pharma, Aurobindo Pharma Ltd, Chartwell Rx, Dr Reddys, Heritage Pharma Avet, Invagen Pharms, Jubilant Generics, Lupin, Macleods Pharms Ltd, MSN, Sun Pharm, Teva Pharms Usa, Torrent, Watson Labs Teva, and Zydus Pharms. and is included in nineteen NDAs.
The generic ingredient in LURASIDONE is lurasidone hydrochloride. There are twenty-six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the lurasidone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lurasidone
A generic version of LURASIDONE was approved as lurasidone hydrochloride by ACCORD HLTHCARE on January 3rd, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LURASIDONE?
- What are the global sales for LURASIDONE?
- What is Average Wholesale Price for LURASIDONE?
Summary for LURASIDONE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 19 |
| Drug Prices: | Drug price information for LURASIDONE |
| DailyMed Link: | LURASIDONE at DailyMed |
